The global Intravascular Ultrasound (IVUS) and Optical Coherence Tomography (OCT) market is poised for strong growth from 2025 to 2034, driven by the increasing prevalence of cardiovascular diseases (CVDs), advancements in AI-integrated imaging systems, and rising adoption in clinical decision-making and interventional cardiology.
These imaging technologies are critical in assessing vessel morphology, detecting plaque, guiding stent placement, and minimizing procedure-related complications.
Key Market Insights
-
North America held ~48% of the global market in 2024.
-
Asia Pacific is projected to grow at the fastest rate through 2034.
-
The IVUS segment dominated with ~58% market share in 2024.
-
The OCT segment is expected to grow at >8% CAGR during the forecast period.
-
By product, imaging catheters led the market in 2024.
-
Imaging consoles/systems are projected to be the fastest-growing segment moving forward.
Top Companies in the IVUS and OCT Market
1. Philips
-
About: A leading Dutch multinational in healthcare technology.
-
Products: IVUS systems (Eagle Eye Platinum catheter, Core Mobile system), and integrated imaging platforms.
-
Market Cap: Approx. $22 billion (as of 2025).
-
Strength: Strong innovation in intravascular imaging and global reach.
2. Abbott
-
About: U.S.-based healthcare giant known for cardiovascular and diagnostic products.
-
Products: Optis™ Integrated OCT Imaging System, Dragonfly™ Imaging Catheters.
-
Market Cap: Around $170 billion (2025).
-
Strength: Extensive clinical adoption and product development for coronary imaging.
3. Boston Scientific
-
About: Major medical device manufacturer headquartered in the U.S.
-
Products: Polaris Multi-Modality Guidance System, OptiCross IVUS catheter.
-
Market Cap: Around $90 billion.
-
Strength: Focus on minimally invasive interventions and advanced image guidance.
4. Terumo Corporation
-
About: A leading Japanese medical technology company.
-
Products: Lunawave IVUS System, Micro Guidewires.
-
Market Cap: Around $25 billion.
-
Strength: Strong in Asia-Pacific, extensive product pipeline in cardiology.
5. ACIST Medical Systems (Bracco Group)
-
About: U.S.-based, part of the Italian Bracco Imaging group.
-
Products: HDi® HD IVUS system, Kodama® catheter.
-
Market Cap: Privately held (Bracco Group estimated value ~$2 billion).
-
Strength: Known for high-definition IVUS imaging solutions.
6. Infraredx (a Nipro Company)
-
About: A U.S. company specializing in intravascular imaging, acquired by Nipro.
-
Products: TVC Imaging System, combining IVUS + NIRS (near-infrared spectroscopy).
-
Market Cap (Nipro): Approx. $4 billion.
-
Strength: Dual imaging technology and coronary plaque characterization.
7. Conavi Medical
-
About: Canadian innovator in hybrid intravascular imaging.
-
Products: Novasight Hybrid System (IVUS + OCT).
-
Market Cap: Private company.
-
Strength: First-in-class hybrid IVUS-OCT imaging in a single catheter.
8. Canon Medical Systems
-
About: A subsidiary of Canon Inc., Japan.
-
Products: Angiography and IVUS solutions (formerly Toshiba Medical).
-
Market Cap (Canon Inc.): Approx. $30 billion.
-
Strength: Integration of imaging modalities and AI capabilities.
9. GE HealthCare
-
About: U.S.-based medtech leader, recently spun off from GE.
-
Products: Developing OCT and vascular imaging platforms.
-
Market Cap: Around $35 billion.
-
Strength: Expanding portfolio with investments in cardiovascular imaging.
10. Siemens Healthineers
-
About: German medtech company with global operations.
-
Products: Advanced imaging platforms, with partnerships for IVUS/OCT.
-
Market Cap: Approx. $60 billion.
-
Strength: AI-enabled diagnostics and hospital integration.
11. Bay Labs (Caption Health)
-
About: U.S.-based AI startup focusing on ultrasound.
-
Products: AI-guided cardiac ultrasound systems.
-
Market Cap: Acquired by GE HealthCare in 2023.
-
Strength: AI innovations for automated intravascular imaging analysis.
12. Kangji Medical (China)
-
About: Leading Chinese manufacturer of minimally invasive surgical devices.
-
Products: Exploring entry into cardiovascular imaging market.
-
Market Cap: Approx. $1.2 billion.
-
Strength: Rapidly expanding product innovation in Asia.
13. Meril Life Sciences (India)
-
About: Indian medical devices firm with global outreach.
-
Products: Imaging-enabled interventional cardiology systems.
-
Market Cap: Private company.
-
Strength: Strong R&D and growing footprint in emerging markets.
14. Medtronic
-
About: One of the world’s largest medical device firms.
-
Products: Coronary imaging tools, acquisition strategy for tech expansion.
-
Market Cap: Approx. $100 billion.
-
Strength: Global leader in CVD treatment with investment in imaging tech.
Request a customized case study tailored to your business needs and gain deeper insights
into healthcare market strategies: sales@towardshealthcare.com
FAQs
1. What is driving the growth of the IVUS and OCT market?
The market is growing due to rising cases of cardiovascular diseases, innovations in imaging technology, and demand for precision-guided interventions using IVUS and OCT.
2. Which region dominates the IVUS and OCT market?
North America holds the largest market share (~48% in 2024), driven by advanced healthcare infrastructure and high adoption rates.
3. Which segment is expected to grow fastest in the coming years?
The OCT segment is expected to register a CAGR of over 8% during 2025–2034 due to its high-resolution imaging capabilities.
4. What role does AI play in IVUS and OCT technologies?
AI is being integrated to improve image analysis, automate plaque detection, and guide stent placement, leading to better procedural outcomes.
5. Are there hybrid imaging systems available?
Yes, companies like Conavi Medical have developed systems that combine IVUS and OCT for comprehensive intravascular imaging in a single procedure.
Invest in Our Premium Strategic Solution: https://www.towardshealthcare.com/price/5894
About the Author
